WO2007022734A8 - A composition for alleviating a hangover comprising hyaluronic acid and activated carbon - Google Patents

A composition for alleviating a hangover comprising hyaluronic acid and activated carbon

Info

Publication number
WO2007022734A8
WO2007022734A8 PCT/CN2006/002190 CN2006002190W WO2007022734A8 WO 2007022734 A8 WO2007022734 A8 WO 2007022734A8 CN 2006002190 W CN2006002190 W CN 2006002190W WO 2007022734 A8 WO2007022734 A8 WO 2007022734A8
Authority
WO
WIPO (PCT)
Prior art keywords
activated carbon
hyaluronic acid
hangover
alleviating
composition
Prior art date
Application number
PCT/CN2006/002190
Other languages
French (fr)
Chinese (zh)
Other versions
WO2007022734A1 (en
Inventor
Peixue Ling
Xiaoyang Pang
Xiaohua Rong
Original Assignee
Peixue Ling
Xiaoyang Pang
Xiaohua Rong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peixue Ling, Xiaoyang Pang, Xiaohua Rong filed Critical Peixue Ling
Priority to JP2008527293A priority Critical patent/JP2009505992A/en
Publication of WO2007022734A1 publication Critical patent/WO2007022734A1/en
Publication of WO2007022734A8 publication Critical patent/WO2007022734A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A composition for alleviating a hangover comprising hyaluronic acid (HA) and activated carbon , and the use of the combination of hyaluronic acid and activated carbon in the manufacture of products for decreasing the absorption of alcohol and/or preventing the toxicity and injury caused by alcohol , and preventing fatty liver , gastric ulcer , gastrorrhagia and so on caused by excess drinking .
PCT/CN2006/002190 2005-08-26 2006-08-25 A composition for alleviating a hangover comprising hyaluronic acid and activated carbon WO2007022734A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008527293A JP2009505992A (en) 2005-08-26 2006-08-25 Drunkenness reducing composition comprising hyaluronic acid and activated carbon

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200510093341.9 2005-08-26
CNB2005100933419A CN100377718C (en) 2005-08-26 2005-08-26 Alcohol-neutralizing agent composition containing hyaluronic acid

Publications (2)

Publication Number Publication Date
WO2007022734A1 WO2007022734A1 (en) 2007-03-01
WO2007022734A8 true WO2007022734A8 (en) 2008-03-20

Family

ID=36075736

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2006/002190 WO2007022734A1 (en) 2005-08-26 2006-08-25 A composition for alleviating a hangover comprising hyaluronic acid and activated carbon

Country Status (3)

Country Link
JP (1) JP2009505992A (en)
CN (1) CN100377718C (en)
WO (1) WO2007022734A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006080449A1 (en) * 2005-01-27 2006-08-03 Seikagaku Corporation Agent for drug clearance and accelerator for drug clearance
CN103043661B (en) * 2012-12-12 2014-11-05 承德鑫永晟炭业有限公司 Method for preparing active carbon for relieving or neutralizing effect of alcohol
CN111956713B (en) * 2020-09-03 2021-10-15 华熙生物科技股份有限公司 Hangover-alleviating and liver-protecting composition containing hyaluronic acid and application thereof
CN112725128A (en) * 2021-03-05 2021-04-30 华熙生物科技股份有限公司 White spirit compound spirit, preparation method and method for reducing drunkenness degree

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1049006C (en) * 1996-12-27 2000-02-02 中国人民解放军第三军医大学 Health-care wine using N-acetyl-D-aminoglucose as additives
CN1280831A (en) * 1999-07-14 2001-01-24 阎小君 Application of activated carbon as sobering-up agent
CN1188110C (en) * 2003-07-10 2005-02-09 凌沛学 Skin cleaning cosmetics containing active carbon, transparent acid and heparin

Also Published As

Publication number Publication date
WO2007022734A1 (en) 2007-03-01
JP2009505992A (en) 2009-02-12
CN1732981A (en) 2006-02-15
CN100377718C (en) 2008-04-02

Similar Documents

Publication Publication Date Title
WO2008101723A3 (en) Pharmaceutical composition containing a cholesterol absorption inhibitor
GB0514463D0 (en) Use of pinolenic acid
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
WO2007017423A3 (en) Pharmaceutical composition comprising a dpp-iv inhibitor
IL196033A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL187163A0 (en) Novel fluorene derivatives, composition containing said derivatives and the use thereof
PL1976855T3 (en) 1-aza-3,7-dioxabicyclo[3.3.0]octane compounds and their use as pro-fragrances
WO2008101682A3 (en) Iminipyridine derivatives and their uses as microbiocides
WO2006122156A3 (en) Compounds for modulating trpv3 function
WO2007115821A3 (en) Organic compounds
WO2007057203A3 (en) Deodorizing super-absorbent composition
WO2007022114A3 (en) Water repellent composition for improving wood product dimensional stability
WO2007106436A3 (en) Photoactive compounds and compositions and uses thereof
WO2006127941A3 (en) Amorphous cinacalcet hydrochloride and preparation thereof
WO2007018570A3 (en) Absorbing film
HK1085499A1 (en) Modified alcohol acid resin oil composition and water-scouring smear-free carving intaglio containing same
ZA200801629B (en) Phenyl - and pyridinyl - 1, 2, 4 - oxadiozolone derivatives, processes for their preparation and their use as pharmaceuticals
AU2006321904A8 (en) 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors
WO2006099232A3 (en) Antimicrobial pet wipes
WO2007003264A3 (en) Polyaspartic acid derivatives in covering agents containing polysiloxane
EP1897910A4 (en) Resin composition, and film, sheet or laminate formed from the same
WO2007144057A3 (en) Antimicrobial carbon
WO2007022734A8 (en) A composition for alleviating a hangover comprising hyaluronic acid and activated carbon
HK1118804A1 (en) Novel unsaturated fatty hydroxy acid derivatives and the dermocosmetologic use thereof
WO2005067906A3 (en) Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2008527293

Country of ref document: JP

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06775508

Country of ref document: EP

Kind code of ref document: A1